ABBV AbbVie Inc.
$286.39▼ -0.12%
Healthcare
Other
Pre-market
$284.17▼ -0.78%
Oct 28, 5:08 AM ET
Volume 3.27M
Avg Volume (10D) 5.13M
Key Metrics & Fundamentals
Market Cap
$506.08B
P/E Ratio
80.9
Div Yield
2.41%
52W Range
190.75 - 291.40
% vs 50 MA
7.04%
% vs 200 MA
21.35%
RSI-14
65.6
MACD Histogram
+0.3000
Beta (1Y vs SPY)
-0.15
Free Cash Flow
$3.11B
Gross Rev
$16.99B
Gross Profit
$12.70B
EBITDA
$7.20B
COGS
$4.29B
Operating Exp
$5.98B
Operating Income
$6.72B
EBIT
$6.72B
Pretax Income
$4.28B
Net Income
$3.61B
EPS (Diluted)
2.03
Price & Volume History
Loading chart…
Recent News

Should You Buy Bristol Myers Squibb Stock For Its Cash?
Trefis · Oct 28, 2026 5:25 AM ET

If Eli Lilly Stock Looks Expensive, You Need To Read This
Trefis · Oct 28, 2026 5:25 AM ET

What Did Halozyme Stock Investors Miss Before The Run?
Trefis · Oct 28, 2026 5:24 AM ET

What to Watch This Week: Fed Meeting, More Tech Earnings
The Wall Street Journal · Oct 28, 2026 4:15 AM ET

The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie
Zacks · Oct 28, 2026 3:29 AM ET

Has Regeneron Stock Become A Different Bet?
Trefis · Oct 27, 2026 12:44 PM ET

4 Arthritis Drug Stocks Investors Should Monitor for Growth Potential
Zacks · Oct 27, 2026 11:16 AM ET

Buy, Hold or Sell ABBV Stock? Key Tips Ahead of Q3 Earnings
Zacks · Oct 27, 2026 10:32 AM ET

What's in Store for These 5 Drug/Biotech Stocks in Q3 Earnings?
Zacks · Oct 27, 2026 9:47 AM ET
AbbVie Seeks FDA Approval for Etentamig in Multiple Myeloma
MT Newswires · Oct 27, 2026 9:22 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ABBV's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.